Point72 Asset Management, L.P. - 31 Mar 2025 SCHEDULE 13G/A Report for Whitehawk Therapeutics, Inc. Common Stock, par value $0.0001 per share (WHWK)

Filing Manager
Point72 Asset Management, L.P.
Reporting Manager
Point72 Asset Management, L.P.
Security
Whitehawk Therapeutics, Inc. Common Stock, par value $0.0001 per share
Symbol
WHWK
Disclosed Ownership
5,087 shares
Ownership
0%
Form type
SCHEDULE 13G/A
Filing time
15 May 2025, 15:53:40 UTC
Date of event
31 Mar 2025
Previous filing
29 Jan 2025
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"Point72 Asset Management, L.P. disclosed 0% ownership in Whitehawk Therapeutics, Inc. Common Stock, par value $0.0001 per share (WHWK) on 31 Mar 2025."

Quick Takeaways

  • Point72 Asset Management, L.P. filed SCHEDULE 13G/A for Whitehawk Therapeutics, Inc. Common Stock, par value $0.0001 per share (WHWK).
  • Disclosed ownership: 0%.
  • Date of event: 31 Mar 2025.

What Changed

  • Previous schedule filing date: 29 Jan 2025.
  • Current filing was accepted on 15 May 2025, 15:53.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Point72 Asset Management, L.P. 0% 5,087 0 5,087 /s/ Jason M. Colombo Jason M. Colombo, Authorized Person
Point72 Capital Advisors, Inc. 0% 5,087 0 5,087 /s/ Jason M. Colombo Jason M. Colombo, Authorized Person
Steven A. Cohen 0% 5,087 0 5,087 /s/ Jason M. Colombo Jason M. Colombo, Authorized Person

Sponsored